[1] Giraud P,Antoine M,Larrouy A,et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000,48:1015-1024. [2] Wanet M,Lee JA,Weynand B,et al. Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches,CT and surgical specimens. Radiother Oncol,2011,98:117-125. [3] Fleckenstein J,Hellwig D,Kremp S,et al. F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial. Int J Radiat Oncol Biol Phys,2011,81:283-289. [4] De Ruysscher D,Wanders S,Wanders S,et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol,2005,77:5-10. [5] Han D,Yu J,Yu Y,et al. Comparison of(18)F-fluorothymidine and(18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus. Int J Radiat Oncol Biol Phys,2010,76:1235-1241. [6] Ma Y,Li M,Yin Y,et al. Hypofractionated stereotactic radiotherapy for brain metastases: a dosimetric and treatment efficiency comparison between volumetric modulated arc therapy and intensity modulated radiotherapy. Technol Cancer Res Treat,2010,9:499-507. [7] 张瑞,习勉,李巧巧,等.胸上段食管癌容积旋转调强和静态调强与三维适形放疗计划的剂量学比较. 中山大学学报(医学科学版),2012,33:260-264. [8] Mac MM,Hicks RJ. The use of positron emission tomography(PET) in the staging/evaluation,treatment,and follow-up of patients with lung cancer: a critical review. Int J Radiat Oncol Biol Phys,2008,72:1298-306. [9] 杨文锋,谭国柱,付政,等.(18)F-FDG PET-CT与强化CT对非小细胞肺癌区域淋巴结诊断价值的评价.中华肿瘤杂志,2009,31:925-928. [10] Madani I,Duthoy W,Derie C,et al. Positron emission tomography-guided,focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys,2007,68:126-135. [11] Shields AF,Grierson JR,Dohmen BM,et al. Imaging proliferation in vivo with[F-18]FLT and positron emission tomography. Nat Med,1998,4:1334-1336. [12] Yue J,Chen L,Cabrera AR,et al. Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study. J Nucl Med,2010,51:528-534. [13] Grosu AL,Weber WA. PET for radiation treatment planning of brain tumours. Radiother Oncol,2010,96:325-327. [14] Gehler B,Paulsen F,Oksuz MO,et al.[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiat Oncol,2009,4:56. [15] Picchio M,Giovannini E,Crivellaro C,et al. Clinical evidence on PET/CT for radiation therapy planning in prostate cancer. Radiother Oncol,2010,96:347-350. [16] Meng X,Loo BW Jr,Ma L,et al. Molecular imaging with 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study. J Nucl Med,2011,52:1573-1579.